Leydig cell tumor – An uncommon paediatric testicular tumor

Aditya Pratap Singh; Dinesh Kumar Barolia; Harsha Vinod Bathia; Vipal H Parmar; Bhavana Asit Mehta; Shraddha Mehta

IP Journal of Surgery and Allied Sciences

Official Publication of Khyati Education and Research Foundation

IP Journal of Surgery and Allied Sciences

Online ISSN: 2582-6387

IP Journal of Surgery and Allied Sciences (JSAS) open access, peer-reviewed quarterly journal publishing since 2019 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article ‘Ahead more...

Article type

Letter to editor

Article page

136-137

Authors Details

Aditya Pratap Singh, Dinesh Kumar Barolia*, Harsha Vinod Bathia, Vipal H Parmar, Bhavana Asit Mehta, Shraddha Mehta

Article Metrics

View Article As

Downlaod Files

Bookmark article

Article Indexing

Citation Managers

Download Citation

Article statistics

Viewed: 212

PDF Downloaded: 75

Leydig cell tumor – An uncommon paediatric testicular tumor

Letter to editor

Author Details : Aditya Pratap Singh, Dinesh Kumar Barolia*, Harsha Vinod Bathia, Vipal H Parmar, Bhavana Asit Mehta, Shraddha Mehta

Volume : 5, Issue : 4, Year : 2023

Article Page : 136-137

https://doi.org/10.18231/j.jsas.2023.032

Suggest article by email

Get Permission

Abstract

How to cite : Singh A P, Barolia D K, Bathia H V, Parmar V H, Mehta B A, Mehta S, Leydig cell tumor – An uncommon paediatric testicular tumor. IP J Surg Allied Sci 2023;5(4):136-137

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.